Teladoc's (TDOC) InTouch Health Acquisition is "Largely Complementary" - Stifel
Tweet Send to a Friend
Stifel analyst David Grossman reiterated a Hold rating and $83.00 price target on Teladoc (NYSE: TDOC) but sees the acquisition ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
